A Rebound in the Markets?

A Rebound in the Markets?

We had a nice little rebound in the markets last week. The Stochastics indicator on the S&P 500 suggests this rebound could go further. Looking at other recent rebounds, last week’s progress may take the S&P well above 1900. However, we are still in the early part of earnings season. The seasonal charts for the → Read More

Flash Boys: High Frequency Trading Exposed

Flash Boys: High Frequency Trading Exposed

Michael Lewis reveals with extraordinary transparency through an engaging character-driven narrative how high frequency trading has impacted the markets from the most sophisticated institutional investor to the individual and everyone in between. For anybody with a keen interest in understanding how the markets really work, this is another must-read from Michael Lewis. Read More

The Story of How Horizon Pharma Creatively Scaled

The Story of How Horizon Pharma Creatively Scaled

In the world of finance and stocks, there are times when “the stars line up” to create an especially interesting story. Such was the case when the announcement was made in March that Chicago-area Horizon Pharma Inc. was joining forces with privately held Vidara Therapeutics (a company which is listed as being headquartered in Roswell, → Read More

How Bad Is The Market Right Now?

How Bad Is The Market Right Now?

How bad is the market? Every trader and investor who pays attention to the markets is trying to answer that question right now. Since the beginning of the year, Goldman Sachs (GS) is down 15.5%, Amazon.com (AMZN) is down 23.6%, and Staples (SPLS) is down 25.7%. But before concluding a bear market has begun, consider → Read More

Raise or Fold?

Raise or Fold?

Draw an trendline on the S&P 500 chart from the November 2012 low and it happens to currently coincide with the big round-number 1800 level. With no other support levels nearby, 1800 will be an important psychological level for the S&P. Unless a new wave of optimism blows in, the magic 1800 level will attract → Read More

Getting Out In Time

Getting Out In Time

In Friday’s Seasonal Forecaster newsletter (4/4/2014), I pointed out one of our best stocks of the past several months had changed in character. Covance (CVD) had twice tried to break to new highs, and both times it immediately broke down on high volume. Compared to the past year where most above-average volume days were on → Read More

The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.